Pulmonary ischaemia–reperfusion injury accounts for significant morbidity after lung transplant but has no known medical therapies. This study identified a critical role for the natural killer cell co-receptor CD94 in mouse and human lung transplant.
Read the article | Submit to the European Respiratory Journal
Friday 11 October 2024
ERJ pick of the week
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment